BTR Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.38M | Sell |
17,765
-100
| -0.6% | -$14.3K | 0.37% | 52 |
|
|
2022
Q2 | $2.74M | Sell |
17,865
-1,573
| -8% | -$240K | 0.39% | 52 |
|
|
2022
Q1 | $3.15M | Sell |
19,438
-227
| -1% | -$33K | 0.39% | 52 |
|
|
2021
Q4 | $2.66M | Buy |
19,665
+1,395
| +8% | +$165K | 0.3% | 54 |
|
|
2021
Q3 | $1.97M | Sell |
18,270
-90
| -0.5% | -$10.3K | 0.24% | 58 |
|
|
2021
Q2 | $2.07M | Buy |
18,360
+1,423
| +8% | +$160K | 0.26% | 57 |
|
|
2021
Q1 | $1.83M | Sell |
16,937
-550
| -3% | -$58.8K | 0.27% | 58 |
|
|
2020
Q4 | $1.87M | Buy |
17,487
+1,058
| +6% | +$102K | 0.29% | 55 |
|
|
2020
Q3 | $1.44M | Sell |
16,429
-1,597
| -9% | -$150K | 0.25% | 59 |
|
|
2020
Q2 | $1.77M | Buy |
18,026
+250
| +1% | +$22K | 0.33% | 52 |
|
|
2020
Q1 | $1.35M | Sell |
17,776
-2,467
| -12% | -$210K | 0.3% | 58 |
|
|
2019
Q4 | $1.79M | Hold |
20,243
| – | – | 0.31% | 58 |
|
|
2019
Q3 | $1.53M | Sell |
20,243
-40
| -0.2% | -$2.74K | 0.29% | 65 |
|
|
2019
Q2 | $1.48M | Sell |
20,283
-1,405
| -6% | -$110K | 0.27% | 68 |
|
|
2019
Q1 | $1.75M | Sell |
21,688
-1,495
| -6% | -$122K | 0.34% | 60 |
|
|
2018
Q4 | $2.14M | Sell |
23,183
-2,120
| -8% | -$186K | 0.45% | 51 |
|
|
2018
Q3 | $2.39M | Buy |
25,303
+1,400
| +6% | +$133K | 0.42% | 50 |
|
|
2018
Q2 | $2.21M | Sell |
23,903
-585
| -2% | -$57.1K | 0.43% | 50 |
|
|
2018
Q1 | $2.32M | Buy |
24,488
+1,810
| +8% | +$199K | 0.46% | 47 |
|
|
2017
Q4 | $2.19M | Sell |
22,678
-298
| -1% | -$28.1K | 0.43% | 49 |
|
|
2017
Q3 | $2.04M | Sell |
22,976
-1,225
| -5% | -$93.3K | 0.42% | 50 |
|
|
2017
Q2 | $1.75M | Sell |
24,201
-6,665
| -22% | -$448K | 0.36% | 54 |
|
|
2017
Q1 | $2.01M | Sell |
30,866
-24,640
| -44% | -$1.55M | 0.42% | 51 |
|
|
2016
Q4 | $3.5M | Hold |
55,506
| – | – | 0.79% | 42 |
|
|
2016
Q3 | $3.5M | Sell |
55,506
-15,351
| -22% | -$994K | 0.79% | 42 |
|
|
2016
Q2 | $4.39M | Sell |
70,857
-1,585
| -2% | -$96.6K | 1.01% | 39 |
|
|
2016
Q1 | $4.14M | Sell |
72,442
-15
| -0% | -$836 | 0.96% | 40 |
|
|
2015
Q4 | $4.29M | Sell |
72,457
-11,388
| -14% | -$656K | 0.98% | 39 |
|
|
2015
Q3 | $4.56M | Buy |
83,845
+1,926
| +2% | +$125K | 1.09% | 36 |
|
|
2015
Q2 | $5.5M | Sell |
81,919
-5,521
| -6% | -$360K | 1.3% | 28 |
|
|
2015
Q1 | $5.12M | Buy |
87,440
+860
| +1% | +$52K | 1.24% | 28 |
|
|
2014
Q4 | $5.67M | Sell |
86,580
-4,955
| -5% | -$312K | 1.55% | 24 |
|
|
2014
Q3 | $5.29M | Buy |
91,535
+18,935
| +26% | +$1.05M | 1.46% | 28 |
|
|
2014
Q2 | $4.1M | Buy |
72,600
+1,875
| +3% | +$98.4K | 1.12% | 37 |
|
|
2014
Q1 | $3.63M | Buy |
70,725
+2,175
| +3% | +$110K | 1.06% | 38 |
|
|
2013
Q4 | $3.62M | Buy |
68,550
+1,850
| +3% | +$90.9K | 1.03% | 36 |
|
|
2013
Q3 | $2.98M | Buy |
66,700
+7,525
| +13% | +$334K | 0.94% | 41 |
|
|
2013
Q2 | $2.45M | Buy |
+59,175
| New | +$2.59M | 0.76% | 46 |
|
Other funds holding ABBV
BTR Capital Management's ABBV Position: Q3 2022 in Review
BTR Capital Management reduced its AbbVie (ABBV) stake by 0.56% in Q3 2022, selling an estimated $14.3K and leaving 17,765 shares worth $2.38M. The position accounts for 0.37% of the portfolio, ranked #52.
BTR Capital Management first reported a position in ABBV in Q2 2013 and has held it in 38 quarters since. The position peaked at $5.67M in Q4 2014. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.
- BTR Capital Management held 17,765 shares of AbbVie worth $2.38M as of Q3 2022.
- BTR Capital Management sold 100 AbbVie shares in Q3 2022, an estimated $14.3K.
- AbbVie made up 0.37% of BTR Capital Management's portfolio in Q3 2022, its #52 holding.
- BTR Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 38 quarters since.
- BTR Capital Management's AbbVie position peaked at $5.67M in Q4 2014.
- 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.
Based on BTR Capital Management's 13F filing for Q3 2022, filed 12 Oct 2022.